>
Organization
Vertex Pharmaceuticals, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Vertex Pharmaceuticals, Inc.

... latest key findings for all current investors, traders, and shareholders of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), MISONIX, Inc. (NASDAQ:MSON), Whiting Petroleum Corporation (NYSE:WLL), Kewaunee Scientific Corporation ...
... Vertex has been at a standstill with U.K. authorities over its cystic fibrosis ...
... Sickle Cell Disease: In the U.S., CRISPR Therapeutics, together with its partner, Vertex, recently announced that the FDA lifted the clinical hold on the CTX001 ...
... affairs. Paone was formerly head of North American regulatory affairs strategy at Vertex Pharmaceuticals. "Antoinette brings crucial experience in clinical regulatory strategy, CMC, and pediatric ...
... The European Commission has approved London-based Vertex's Symkevi (ivacaftor+tezacaftor) in combination with ivacaftor for patients with specific mutations in ...
... of one of 14 mutations that result in residual CFTR activity - Vertex Pharmaceuticals (Europe) Limited, today announced that the European Commission has granted Marketing ...
... Cystic Fibrosis Foundation helped fund the work through a grant to Vertex Pharmaceuticals Inc., which is developing both experimental drugs. "The ability of these potential ...
... 30, 2018 and reviewed recent progress with its approved and investigational medicines. Vertex also reiterated its guidance for full-year 2018 total CF product revenues and ...
... Vertex has halted development of VX-210 after a phase 2b acute spinal cord ...
Subscribe now for full coverage on Vertex Pharmaceuticals, Inc.
Start My Free Trial